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Abstract: Chemoinformatics techniques were originally developed for the construction and searching
of large archives of chemical structures but they were soon applied to problems in drug discovery and
are now playing an increasingly important role in many additional areas of chemistry. This Special
Issue contains seven original research articles and four review articles that provide an introduction to
several aspects of this rapidly developing field.
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Chemistry is, and has been for many years, one of the most information-rich academic disciplines.
The very first journal devoted to chemistry was published as early as 1778, and the literature has
grown steadily since then. Much of the information in chemistry relates to the structures—in both two
and three dimensions—of individual chemical molecules; for example, the world‘s largest chemical
database, the Chemical Registry produced by Chemical Abstracts Service, now contains the structures
of over 90 million distinct molecules, and there are additional millions in other public databases and
in the corporate files of pharmaceutical, agrochemical, and biotechnology companies. This wealth of
information has spurred the development of a specialist discipline, that of chemoinformatics, which
Gasteiger defines as “the application of informatics methods to solve chemical problems” [1]. Gasteiger
has been one of the founding fathers of chemoinformatics, and his review included in this special issue
provides a personal view of the history and development of the discipline over the past 50 years. As
he notes, the novel modes of access that chemoinformatics provides to even the largest volumes of
chemical information have profoundly affected the ways in which chemical research is conducted. That
this is so is evidenced by the original research articles and review articles that comprise this special
issue, since they provide an overview of current activity in this rapidly developing, and increasingly
important field of chemistry.
The structure of a molecule is a prime factor in determining its physical, chemical, and biological
properties, and chemoinformatics draws on techniques from areas such as graph theory, multivariate
statistics, and machine learning to provide sophisticated data mining facilities to correlate such
properties with structure (however this is represented in computational form). Such correlation
approaches lie at the heart of virtual screening, which is probably the most important current
application of chemoinformatics. Virtual screening involves scanning a database—either of known
molecules or of molecules that could in principle be made—to identify those with the greatest
probabilities of exhibiting some property of interest, e.g., affecting an individual’s cholesterol level
or the viscosity of a lubricant. Several of the research articles in this issue discuss applications of
virtual screening. The first two such studies involve the use of similarity approaches. Al-Dabbagh et al.
report the development of a new family of similarity measures, called Standard Quantum-Based
similarity, and describe their use in ligand-based virtual screening using the well-known MDDR,
MUV and DUD datasets. Comparable experiments using conventional, fingerprint-based similarity
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searching demonstrate the effectiveness of the new approach [2]. Shin et al. describe an evaluation
of four different methods for computing 3D shape similarities. Their experiments used a benchmark
dataset based on 22 important therapeutic targets (such as viral pathogens, steroid receptor targets,
and GPCRs) and compared the methods in terms of both computational efficiency and screening
effectiveness [3].
Two other articles discuss the use of machine learning methods for virtual screening. These
methods, such as support vector machine (SVM) or random forest (RF), have become increasingly
popular with the availability of greater volumes of structure and activity data for the construction
of training sets. Czarnecki et al. describe the development of new algorithms—the Extreme Entropy
Machine and Extremely Randomized Trees—for predicting bioactivity, and find that they are both
more effective and computationally more efficient than SVM and RF, their non-extreme analogues [4].
RFs are also the focus of the study by Li et al. [5]. These authors found that, contrary to what might
have been expected, the inclusion of low-quality structural and binding data in an RF-based scoring
function for a docking algorithm improved the function’s predictive performance.
The remaining research articles cover a diverse range of topics. Mallochi et al. report some of the
initial results from a long-term project to construct a database of medicinal compounds that provides
for each such compound all-atom parameters compatible with different existing biological force fields,
microsecond-long dynamics and physico-chemical descriptors in different physiological conditions [6].
Winters-Hilt and Stoyanov discuss the use of an α-hemolysin nanopore transduction detector for
a range of applications in biochemistry, biomedical engineering, and biotechnology [7]. Finally,
Salmina et al. describe an extensive set of manually curated extended functional groups that they
have developed for use as descriptors in QSAR and QSPR studies, illustrating the application of these
groups to regression and classification tasks on over 20 datasets for which associated physico-chemical
or biological property data are available [8].
The review articles are equally wide ranging in character. After providing an overview of
pharmacophore modelling and pharmacophore-based virtual screening, Kaserer et al. illustrate the use
of these techniques with hydroxysteroid dehydrogenases, which are promising therapeutic targets
for the treatment of a range of estrogen- and androgen-dependent diseases [9]. Another important
biological target is discussed by Kim and Yang, who review the use of structure-based virtual screening
in combination with high-throughput screening for the identification of small-molecule inhibitors of
hypoxia-inducible factor prolyl hydroxylases [10]. Wang reviews the work of his group and of others
on the PI3K/Akt/mTOR pathway, which is a key factor in cellular responses to extracellular stimuli.
As Wang notes, while molecular dynamics simulations have long played an important role in drug
discovery, they consider only individual molecules; if accurate predictions of biological function are
to be achieved then it will be necessary to develop systems dynamics simulations that can model the
complex network of interactions between all of the many molecules in a cell [11].
In closing, it is pleasant to note the widespread interest that chemoinformatics is now attracting,
with contributions here from Austria, France, Germany, Italy, Malaysia, the People’s Republic of
China, Poland, South Korea, the Sudan, Switzerland and the United States of America. I thank all
of the authors for their contributions to this Special Issue and the staff members of MDPI for their
editorial support.
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